[EN] 2-((5-(PHENYL)-PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)AMINO)-3-(PHENYL)PROPANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS MCL-1 ENZYME INHIBITORS FOR TREATING CANCER<br/>[FR] DÉRIVÉS D'ACIDE 2-((5-(PHÉNYL)-PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)AMINO)-3-(PHÉNYL)PROPANOÏQUE ET COMPOSÉS APPARENTÉS SERVANT D'INHIBITEURS D'ENZYME MCL-1 POUR LE TRAITEMENT DU CANCER
申请人:PRELUDE THERAPEUTICS INC
公开号:WO2020123994A1
公开(公告)日:2020-06-18
A compound of formula I (the variables are defined in the claims) or a pharmaceutically acceptable salt or solvate thereof, as an MCL-1 enzyme inhibitor for treating colon cancer, breast cancer, small-cell lung cancer, non-small- cell lung cancer, bladder cancer, ovarian cancer, prostate cancer, chronic lymphoid leukemia, lymphoma, myeloma, acute myeloid leukemia, or pancreatic cancer. The present description discloses the synthesis of exemplary compounds as well as biological assays thereof (e.g. pages 55 to 114; paragraphs [00216] to [00304]; examples 1 to 33; tables A and 2). An exemplary compound is e.g. (2R)-2-[(5Ra)-5-3-chloro-2-methyl-4-[2-(4-methylpiperazin-l-yl) ethoxy]phenyl}-6-(4-fluorophenyl) py rrolo[2, l-f][l, 2, 4]triazin-4-yl]am ino}-3-(2-[2-(2-methoxy phenyl) py rim idin-4-yl]methoxy} phenyl) propanoic acid (example 13) with e.g. 0.7 nM BIM_Ki in an cell free MCL-1 Bim affinity assay.
化合物I的化学式(变量在权利要求中定义)或其药学上可接受的盐或溶剂,作为MCL-1酶抑制剂,用于治疗结肠癌、乳腺癌、小细胞肺癌、非小细胞肺癌、膀胱癌、卵巢癌、前列腺癌、慢性淋巴细胞白血病、淋巴瘤、骨髓瘤、急性髓系白血病或胰腺癌。本说明书披露了示例化合物的合成以及生物测定(例如第55至114页;段落[00216]至[00304];示例1至33;表A和2)。例如,一种示例化合物是(2R)-2-[(5Ra)-5-3-氯-2-甲基-4-[2-(4-甲基哌嗪-1-基)乙氧基]苯基}-6-(4-氟苯基)吡咯[2,1-f][1,2,4]三嗪-4-基]氨基}-3-(2-[2-(2-甲氧基苯基)嘧啶-4-基]甲氧基}苯基)丙酸(示例13),在无细胞MCL-1 Bim亲和力测定中,其BIM_Ki为0.7 nM。